These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31469905)

  • 1. Monitoring for Thyroid Cancer Recurrence.
    Peiris AN
    Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469905
    [No Abstract]   [Full Text] [Related]  

  • 2. Papillary carcinoma of the thyroid: balancing principles of oncology with emerging technology.
    Evans DB
    Surgery; 2011 Dec; 150(6):1015-22. PubMed ID: 22136816
    [No Abstract]   [Full Text] [Related]  

  • 3. Empirically treating high serum thyroglobulin levels.
    Mazzaferri EL
    J Nucl Med; 2005 Jul; 46(7):1079-88. PubMed ID: 16000275
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recurrence of differentiated thyroid carcinoma without concomitant elevation of serum thyroglobulin: report of two cases].
    Velasco S; Solar A; Cruz F; Quintana JC; León A; Mosso L; Fardella C
    Rev Med Chil; 2007 Apr; 135(4):506-11. PubMed ID: 17554461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level.
    Elisei R; Agate L; Viola D; Matrone A; Biagini A; Molinaro E
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):331-44. PubMed ID: 24891165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma.
    Schlumberger M; Baudin E
    Eur J Endocrinol; 1998 Mar; 138(3):249-52. PubMed ID: 9539294
    [No Abstract]   [Full Text] [Related]  

  • 7. Do all cancers need to be treated? The role of thyroglobulin in the management of thyroid cancer: the 2006 Hayes Martin lecture.
    Heller KS
    Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):639-43. PubMed ID: 17638774
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
    Whitley RJ; Ain KB
    Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroglobulin and recurrence of thyroid cancer.
    Miwanitkit V
    S Afr J Surg; 2012 Mar; 50(2):52. PubMed ID: 22622106
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyroglobulin for Monitoring for Thyroid Cancer Recurrence.
    Peiris AN; Medlock D; Gavin M
    JAMA; 2019 Mar; 321(12):1228. PubMed ID: 30912839
    [No Abstract]   [Full Text] [Related]  

  • 11. Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound?
    Schlumberger M
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):119-20. PubMed ID: 15670184
    [No Abstract]   [Full Text] [Related]  

  • 12. Interlaboratory comparison of thyroglobulin measurements for patients with recurrent or metastatic differentiated thyroid cancer.
    Morris LF; Waxman AD; Braunstein GD
    Clin Chem; 2002 Aug; 48(8):1371-2. PubMed ID: 12142399
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroglobulin and thyroid cancer.
    Lo Gerfo P; Birnbaum S; Li Volsi V; Scholes J
    Surg Forum; 1977; 28():133-5. PubMed ID: 617395
    [No Abstract]   [Full Text] [Related]  

  • 14. On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma.
    Gholamrezanezhad A; Saghari M; Mirpour S; Beiki D; Tarbiat A; Javan S; Abdollahzadeh J
    Endokrynol Pol; 2007; 58(2):100-4. PubMed ID: 17578824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for the management of differentiated thyroid cancers].
    Ann Endocrinol (Paris); 2007 Dec; 68 Suppl 2():S57-72. PubMed ID: 18342281
    [No Abstract]   [Full Text] [Related]  

  • 16. Surveillance for Differentiated Thyroid Cancer Recurrence.
    Santhanam P; Ladenson PW
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):239-252. PubMed ID: 30717906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preablative serum thyroglobulin as predictor of disease-free survival in differentiated thyroid cancer].
    Díaz RE; Véliz J; Wohllk N
    Rev Med Chil; 2013 Dec; 141(12):1506-11. PubMed ID: 24728426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing concepts in the management of differentiated thyroid cancer.
    Intenzo CM; Jabbour S; Dam HQ; Capuzzi DM
    Semin Nucl Med; 2005 Oct; 35(4):257-65. PubMed ID: 16150246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
    Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
    Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of serum thyroglobulin in differentiated thyroid cancer. A review and 3 cases].
    Feldt-Rasmussen U; Hansen HS; Rasmusson B
    Ugeskr Laeger; 1983 Apr; 145(15):1132-6. PubMed ID: 6879741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.